Taysha Gene Therapies Inc (TSHA) valuation · rev $9.8M
Taysha Gene Therapies Inc (TSHA) rev $9.8M.
| Metric | Value |
|---|---|
| Market cap | $640.7M |
| Revenue | $9.8M |
| P/S | 65.6 |
TSHA valuation FAQ
What is TSHA's market cap?
Taysha Gene Therapies Inc (TSHA) market cap is $640.7M on the latest cached fundamentals snapshot.
What is TSHA's latest revenue?
Latest cached Taysha Gene Therapies Inc (TSHA) revenue was $9.8M. Statements: https://lician.com/financials/tsha
What is TSHA's price-to-sales ratio?
Taysha Gene Therapies Inc (TSHA) price-to-sales (P/S) is 65.6, cached market cap $640.7M divided by revenue $9.8M.
How many TSHA valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Taysha Gene Therapies Inc (TSHA): Market cap, Revenue, and P/S.
Where is TSHA valuation listed?
Cached valuation multiples for Taysha Gene Therapies Inc (TSHA) are listed at https://lician.com/valuation/tsha.
Not investment advice. Cached rows, not a live tape.